Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,416.00
Bid: 12,408.00
Ask: 12,410.00
Change: -12.00 (-0.10%)
Spread: 2.00 (0.016%)
Open: 12,474.00
High: 12,480.00
Low: 12,350.00
Prev. Close: 12,428.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Earnings come in mixed as investors watch US data, Fed

Thu, 31st Jul 2014 12:04

- Shell, BG Group and Intu lead the risers- Weir, Schroders and Lloyds fall- Afren drops after suspending directors- US data and Fed keep investors cautioustechMARK 2,763.54 -0.57%FTSE 100 6,763.04 -0.15%FTSE 250 15,495.73 -0.86%London stocks were trading in the red for a second straight day on Thursday as investors gave a mixed reaction to a wave of blue-chip corporate earnings and showed their nerves amid policy tightening speculation in the States. Results from Shell, BG Group, Intu Properties impressed the market in morning trade, offset by falls from Weir, Schroders and Lloyds. Meanwhile, the share price of oil explorer Afren plummeted after the company suspended two directors.The FTSE 100 was down 0.15% at 6,763 around midday.The Federal Reserve decided on Wednesday night to taper stimulus by $10bn a month for the sixth straight time, putting the central bank on course to end its quantitative easing programme in October.However, with the end of monetary stimulus now fast approaching, Wednesday's better-than-expected US growth figures - economy expanded by 4% in second quarter - traders are now concerned that policymakers could be tempted to raise interest rates sooner than expected.Jasper Lawler, a market analyst at CMC Markets, said that Fed Chair Janet Yellen had aimed to be "dovish while demonstrating a gradual hawkish shift" in the Fed's statement on Wednesday. However, with growth above expectations and inflation running at the target 2% amid a strengthening labour market, he said the "markets didn't really buy the Fed's attempt at dovishness"."After growth and inflation, Friday's non-farm payrolls will be the third point in the rate hike 'triangle', another 200k+ report and unemployment below 6% means the Fed really have no excuses not to tighten," he said.The consensus forecast for the all-important 'official' US employment report is for a 231,000 gain in non-farm payrolls in July, down from an impressive 288,000 in June. The unemployment rate is expected to remain unchanged after falling to 6.1%, its lowest since September 2008.As for Thursday's session, the focus will be on weekly US initial jobless claims, which are predicted to have risen to 300,000 from a post-recession low of 284,000 the previous week.Earnings come in mixedOil major Royal Dutch Shell impressed with shares rising strongly after saying earnings more than doubled in the second quarter to $5.1bn, even when including a $1bn net charge due to impairments. Natural gas group BG Group was also higher as it lifted its interim by a tenth after a strong second quarter led to a 9% increase in earnings per share in the first half.Intu Properties was in favour after the real estate firm said higher rental income helped to lift underlying earnings as the letting market showed "encouraging signs of improvement".Heading the other way banking group Lloyds which underwhelmed after saying that underlying profits improved by 32% to £3.82bn in the first half of the year, ahead of the £3.6bn consensus forecast. This was achieved despite a 2.2% fall in total underlying income to £9.25bn.Engineer Weir was in the red after reporting that profits slid 6% in the first half, reflecting adverse foreign exchange currency exchange rate movements and challenging conditions in the mining industry. Even though it unexpectedly hiked its half-year dividend 50% to 24p, shares in asset manager Schroders slipped after it sounded a note of caution about the retail investor market. Meanwhile, telecoms group BT and drinks giant Diageo both rose after their results, while engine maker Rolls-Royce and drugs group AstraZeneca underwhelmed.On the FTSE 250, Afren shares plummeted after the company said that it has suspended its chief executive officer and chief operating officer as an investigation found "the receipt of unauthorised payments potentially for the benefit of the CEO and COO".FTSE 100 - RisersRoyal Dutch Shell 'B' (RDSB) 2,583.50p +3.80%Royal Dutch Shell 'A' (RDSA) 2,454.00p +3.00%Intu Properties (INTU) 328.60p +2.59%BG Group (BG.) 1,203.00p +1.91%BT Group (BT.A) 390.80p +0.75%GlaxoSmithKline (GSK) 1,435.00p +0.70%BP (BP.) 484.95p +0.66%Diageo (DGE) 1,799.00p +0.56%Antofagasta (ANTO) 820.50p +0.55%easyJet (EZJ) 1,297.00p +0.54%FTSE 100 - FallersWeir Group (WEIR) 2,556.00p -4.20%Schroders (SDR) 2,417.00p -3.28%St James's Place (STJ) 732.00p -3.05%Lloyds Banking Group (LLOY) 74.40p -2.63%Barratt Developments (BDEV) 348.40p -2.60%GKN (GKN) 342.90p -2.39%3i Group (III) 377.70p -2.38%Aggreko (AGK) 1,729.00p -2.26%Sports Direct International (SPD) 670.00p -2.12%Petrofac Ltd. (PFC) 1,089.00p -2.07%FTSE 250 - RisersLaird (LRD) 285.80p +6.76%Hochschild Mining (HOC) 163.40p +2.90%Bodycote (BOY) 710.50p +2.53%Domino's Pizza Group (DOM) 547.00p +1.86%Countrywide (CWD) 524.50p +1.84%Barr (A.G.) (BAG) 661.00p +1.69%Workspace Group (WKP) 607.50p +1.59%Inchcape (INCH) 647.50p +1.57%Thomas Cook Group (TCG) 123.20p +1.07%Rightmove (RMV) 2,258.00p +1.07%FTSE 250 - FallersAfren (AFR) 111.50p -25.07%IP Group (IPO) 181.30p -4.58%Man Group (EMG) 120.50p -4.44%Pace (PIC) 322.60p -4.39%Supergroup (SGP) 1,019.00p -4.23%Bank of Georgia Holdings (BGEO) 2,417.00p -3.09%Homeserve (HSV) 295.30p -2.93%JD Sports Fashion (JD.) 380.10p -2.91%Jupiter Fund Management (JUP) 382.70p -2.87%Ocado Group (OCDO) 333.40p -2.71%BC
More News
22 Jan 2024 11:45

BioNTech challenges AstraZeneca with breast cancer precision drug trial

FRANKFURT, Jan 22 (Reuters) - BioNTech and its partner Duality Biologics said on Monday they initiated a late-stage trial testing their precision drug against a certain type of breast cancer, taking on a rival partnership between AstraZeneca and Daiichi Sankyo.

Read more
19 Jan 2024 09:28

TOP NEWS: AstraZeneca's Voydeya receives approval in Japan for PNH

(Alliance News) - AstraZeneca PLC on Friday said its inhibitor Voydeya, also known as danicopan, received approval in Japan for adults with paroxysmal nocturnal haemoglobinuria, or PNH.

Read more
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.